Abstract
1. Based upon quantitative estimations of the factors that promote or retard the development and activity of the streptococcal fibrinolytic phenomenon, an active lytic system was developed within the circulating blood stream of rabbits following the intravenous infusion of streptokinase. During the infusion of adequate doses of SK, an active lytic system was observed to be present within 30 minutes following the beginning of the experiment and remained present for periods of time ranging from 1 to 20 hours depending primarily upon the concentration of SK and the duration of the infusion. Some of the biochemical changes accompanying the lytic system in vivo were: (a) a striking fall in the plasminogen; (b) a moderate fall in the serum inhibitor and the fibrinogen; and, (c) a rise in the acid-soluble nitrogen. These changes were usually self-terminating within 24 hours following the infusion of SK. In earlier studies similar trends were observed in the chest fluid of patients with hemothorax and empyema treated locally with streptokinase (22). 2. Intravascular clots, induced artificially by local applications of sodium morrhuate within the ear vein of the rabbits, were observed to liquefy and disappear in 23 of 25 rabbits during the intravenous infusion of SK into the opposite ear. The average quantity of SK necessary to effect an active lytic system was found to be about 40,000 units per kilo per hour. The clot in the ear vein was observed to be lysed completely in periods of time ranging from 3 to 7 hours after the infusion of SK was begun. Maintenance of an active lytic system for 3 to 4 additional hours was required to prevent re-formation of the clots at the original site. In 3 of 4 rabbits in which clots did reform, ACTH had been given to combat the toxic effects of the streptococcal concentrates. 3. The toxicity of the unusually large dose of the streptococcal concentrates, containing measured amounts of SK, along with other identifiable and unknown substances, was considerable, inasmuch as 8 animals eventually died. No evidence of pulmonary infarction was observed at autopsy. The administration of ACTH appeared to prevent a fatal outcome in at least 3 of the rabbits. Further studies of toxicity are in progress.
Full Text
The Full Text of this article is available as a PDF (919.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- COSGRIFF S. W., DIEFENBACH A. F., VOGT W., Jr Hypercoagulability of the blood associated with ACTH and cortisone therapy. Am J Med. 1950 Dec;9(6):752–756. doi: 10.1016/0002-9343(50)90290-7. [DOI] [PubMed] [Google Scholar]
- Guest M. M., Daly B. M., Ware A. G., Seegers W. H. A STUDY OF ANTIFIBRINOLYSIN ACTIVITY IN THE PLASMAS OF VARIOUS ANIMAL SPECIES. J Clin Invest. 1948 Nov;27(6):785–792. doi: 10.1172/JCI102029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heidelberger M., Macpherson C. F. QUANTITATIVE MICRO-ESTIMATION OF ANTIBODIES IN THE SERA OF MAN AND OTHER ANIMALS. Science. 1943 Apr 30;97(2522):405–406. doi: 10.1126/science.97.2522.405. [DOI] [PubMed] [Google Scholar]
- LEWIS J. H., FERGUSON J. H. Effects of intravenous injection in dogs of staphylokinase and dog serum fibrinolysin. Proc Soc Exp Biol Med. 1949 Aug;71(4):677–680. doi: 10.3181/00379727-71-17297. [DOI] [PubMed] [Google Scholar]
- SHERRY S., TILLETT W. S., READ C. T. The use of streptokinase-streptodornase in the treatment of hemothorax. J Thorac Surg. 1950 Sep;20(3):393–417. [PubMed] [Google Scholar]
- Tillett W. S., Sherry S. THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS. J Clin Invest. 1949 Jan;28(1):173–190. doi: 10.1172/JCI102046. [DOI] [PMC free article] [PubMed] [Google Scholar]